Literature DB >> 25186056

Heterozygosity for deletion of hypersensitive site 3 in the human locus control region has an unexpected minor effect on red cell phenotype.

Jorge M Nieto1, Ana Villegas1, Felix De La Fuente-Gonzalo1, Fernando A González1, Paloma Ropero1.   

Abstract

The locus control region (LCR) is a genetic region that regulates the expression of the β-globin locus (HBB locus). This region is composed of several DNase I hypersensitive sites (HSs) in which the regulatory functions of the LCR may reside. To date, some individuals bearing deletions of several HSs or even the complete LCR have been described. Although the globin genes of the HBB locus are intact, most of these patients suffer thalassemia due to the reduced expression of such genes. The LCR and the HSs forming it have been thoroughly studied in different genetic models. However, seemingly contradictory results are often obtained. Here, we describe the first deletion found in humans exclusively affecting the HS3 element of the LCR. The adult carrying this deletion shows very mild hematological modifications, indicating that HS3 deletion does not severely impair the β-gene expression. Our results also reveal limitations of the murine models when studying the native mouse genes for understanding human diseases like thalassemias.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25186056     DOI: 10.1038/jhg.2014.76

Source DB:  PubMed          Journal:  J Hum Genet        ISSN: 1434-5161            Impact factor:   3.172


  16 in total

1.  Chromatin structure of the LCR in the human β-globin locus transcribing the adult δ- and β-globin genes.

Authors:  Seoyeon Kim; Yea Woon Kim; Sung Han Shim; Chul Geun Kim; Aeri Kim
Journal:  Int J Biochem Cell Biol       Date:  2011-12-13       Impact factor: 5.085

2.  The hypersensitive sites of the murine β-globin locus control region act independently to affect nuclear localization and transcriptional elongation.

Authors:  M A Bender; Tobias Ragoczy; Jongjoo Lee; Rachel Byron; Agnes Telling; Ann Dean; Mark Groudine
Journal:  Blood       Date:  2012-02-29       Impact factor: 22.113

3.  Deletion of the core region of 5' HS2 of the mouse beta-globin locus control region reveals a distinct effect in comparison with human beta-globin transgenes.

Authors:  Xiao Hu; Michael Bulger; M A Bender; Jennifer Fields; Mark Groudine; Steven Fiering
Journal:  Blood       Date:  2005-09-27       Impact factor: 22.113

4.  A dominant chromatin-opening activity in 5' hypersensitive site 3 of the human beta-globin locus control region.

Authors:  J Ellis; K C Tan-Un; A Harper; D Michalovich; N Yannoutsos; S Philipsen; F Grosveld
Journal:  EMBO J       Date:  1996-02-01       Impact factor: 11.598

5.  The proximal element of the beta globin locus control region is not functionally required in vivo.

Authors:  A E Kulozik; S Bail; A Bellan-Koch; C R Bartram; E Kohne; E Kleihauer
Journal:  J Clin Invest       Date:  1991-06       Impact factor: 14.808

6.  Study of three families with Hb Agrinio [α29(B10)Leu→Pro, CTG>CCG (α2)] in the Spanish population: three homozygous cases.

Authors:  Felix de la Fuente-Gonzalo; Montserrat Baiget; Isabel Badell; Pilar Ricard; Lara Vinuesa; Jorge Martínez-Nieto; Paloma Ropero; Ana Villegas; Fernando A González; Joaquin Díaz-Mediavilla
Journal:  Hemoglobin       Date:  2012-10-24       Impact factor: 0.849

7.  Analysis of mice containing a targeted deletion of beta-globin locus control region 5' hypersensitive site 3.

Authors:  B A Hug; R L Wesselschmidt; S Fiering; M A Bender; E Epner; M Groudine; T J Ley
Journal:  Mol Cell Biol       Date:  1996-06       Impact factor: 4.272

8.  Sickle cell disease caused by heterozygosity for Hb S and novel LCR deletion: Report of two patients.

Authors:  Sara C Koenig; Esmira Becirevic; Miriam S C Hellberg; Michael Y Li; Jason C C So; Jane S Hankins; Russell E Ware; Lillian McMahon; Martin H Steinberg; Hong-Yuan Luo; David H K Chui
Journal:  Am J Hematol       Date:  2009-09       Impact factor: 10.047

9.  Deletion of the mouse alpha-globin regulatory element (HS -26) has an unexpectedly mild phenotype.

Authors:  Eduardo Anguita; Jacqueline A Sharpe; Jacqueline A Sloane-Stanley; Cristina Tufarelli; Douglas R Higgs; William G Wood
Journal:  Blood       Date:  2002-07-05       Impact factor: 22.113

10.  LCR 5' hypersensitive site specificity for globin gene activation within the active chromatin hub.

Authors:  Kenneth R Peterson; Halyna Fedosyuk; Susanna Harju-Baker
Journal:  Nucleic Acids Res       Date:  2012-10-04       Impact factor: 16.971

View more
  1 in total

1.  Hb S/β+-thalassemia due to Hb sickle and a novel deletion of DNase I hypersensitive sites HS3 and HS4 of the β locus control region.

Authors:  Ali Amid; Melina Cheong; Barry Eng; Meredith Hanna; Betty-Ann Hohenadel; Lisa M Nakamura; Lynda Walker; Isaac Odame; Melanie Kirby-Allen; John S Waye
Journal:  Haematologica       Date:  2015-02-14       Impact factor: 9.941

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.